Company news
VivoSim Labs, Inc. news in 2022
VivoSim Labs, Inc.'s news releases, calls and decks from 2022, newest first.
Organovo Announces Target Validation Ahead of Schedule, Accelerating Timeline for First Crohn’s Disease Drug Candidates
November 14, 2022
Organovo to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
September 5, 2022
Organovo Announces Postponement of Annual Meeting of Stockholders
September 5, 2022
Organovo Achieves 3D Tissue Model for Crohn’s Disease
May 16, 2022
UPDATE -- Organovo and BICO (CELLINK) Reach Licensing Agreement on Bioprinting Patents
February 28, 2022
Organovo and BICO (CELLINK) Reach Licensing Agreement on Bioprinting Patents
February 22, 2022
Organovo Welcomes New Sr. Vice President of Strategy and Business Development
February 17, 2022
Organovo Holdings, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
February 17, 2022
Organovo Guides on Patent Portfolio and Successful IPR Defense of Two Patents
February 1, 2022
Organovo Files Counterclaims In Patent Lawsuit Brought Against It by CellInk
January 9, 2022